These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 23332883

  • 1. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy.
    Linder BJ, Frank I, Cheville JC, Tollefson MK, Thompson RH, Tarrell RF, Thapa P, Boorjian SA.
    Eur Urol; 2013 May; 63(5):839-45. PubMed ID: 23332883
    [Abstract] [Full Text] [Related]

  • 2. The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC).
    Linder BJ, Thompson RH, Leibovich BC, Cheville JC, Lohse CM, Gastineau DA, Boorjian SA.
    BJU Int; 2014 Sep; 114(3):368-74. PubMed ID: 24471825
    [Abstract] [Full Text] [Related]

  • 3. Risk factors and outcomes of urethral recurrence following radical cystectomy.
    Boorjian SA, Kim SP, Weight CJ, Cheville JC, Thapa P, Frank I.
    Eur Urol; 2011 Dec; 60(6):1266-72. PubMed ID: 21871713
    [Abstract] [Full Text] [Related]

  • 4. Impact of peri-operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
    Kluth LA, Xylinas E, Rieken M, El Ghouayel M, Sun M, Karakiewicz PI, Lotan Y, Chun FK, Boorjian SA, Lee RK, Briganti A, Rouprêt M, Fisch M, Scherr DS, Shariat SF.
    BJU Int; 2014 Mar; 113(3):393-8. PubMed ID: 24053618
    [Abstract] [Full Text] [Related]

  • 5. The impact of perioperative blood transfusion on survival following radical cystectomy for urothelial carcinoma.
    Sadeghi N, Badalato GM, Hruby G, Kates M, McKiernan JM.
    Can J Urol; 2012 Oct; 19(5):6443-9. PubMed ID: 23040626
    [Abstract] [Full Text] [Related]

  • 6. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study.
    Vetterlein MW, Gild P, Kluth LA, Seisen T, Gierth M, Fritsche HM, Burger M, Protzel C, Hakenberg OW, von Landenberg N, Roghmann F, Noldus J, Nuhn P, Pycha A, Rink M, Chun FK, May M, Fisch M, Aziz A, PROMETRICS 2011 Study Group.
    BJU Int; 2018 Jan; 121(1):101-110. PubMed ID: 28905486
    [Abstract] [Full Text] [Related]

  • 7. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy.
    Rink M, Zabor EC, Furberg H, Xylinas E, Ehdaie B, Novara G, Babjuk M, Pycha A, Lotan Y, Trinh QD, Chun FK, Lee RK, Karakiewicz PI, Fisch M, Robinson BD, Scherr DS, Shariat SF.
    Eur Urol; 2013 Sep; 64(3):456-64. PubMed ID: 23206854
    [Abstract] [Full Text] [Related]

  • 8. Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality?
    Abel EJ, Linder BJ, Bauman TM, Bauer RM, Thompson RH, Thapa P, Devon ON, Tarrell RF, Frank I, Jarrard DF, Downs TM, Boorjian SA.
    Eur Urol; 2014 Dec; 66(6):1139-47. PubMed ID: 25194909
    [Abstract] [Full Text] [Related]

  • 9. Impact of Packed Red Blood Cells and Fresh Frozen Plasma Given During Radical Cystectomy and Urinary Diversion on Cancer-related Outcome and Survival: An Observational Cohort Study.
    Furrer MA, Fellmann A, Schneider MP, Thalmann GN, Burkhard FC, Wuethrich PY.
    Eur Urol Focus; 2018 Dec; 4(6):916-923. PubMed ID: 28951117
    [Abstract] [Full Text] [Related]

  • 10. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
    Viers BR, Boorjian SA, Frank I, Tarrell RF, Thapa P, Karnes RJ, Thompson RH, Tollefson MK.
    Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414
    [Abstract] [Full Text] [Related]

  • 11. Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.
    Lotan Y, Bagrodia A, Passoni N, Rachakonda V, Kapur P, Arriaga Y, Bolenz C, Margulis V, Raj GV, Sagalowsky AI, Shariat SF.
    Eur Urol; 2013 Sep; 64(3):465-71. PubMed ID: 23571005
    [Abstract] [Full Text] [Related]

  • 12. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
    Fajkovic H, Cha EK, Jeldres C, Robinson BD, Rink M, Xylinas E, Chromecki TF, Breinl E, Svatek RS, Donner G, Tagawa ST, Tilki D, Bastian PJ, Karakiewicz PI, Volkmer BG, Novara G, Joual A, Faison T, Sonpavde G, Daneshmand S, Lotan Y, Scherr DS, Shariat SF.
    Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503
    [Abstract] [Full Text] [Related]

  • 13. Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer.
    Boorjian SA, Kim SP, Tollefson MK, Carrasco A, Cheville JC, Thompson RH, Thapa P, Frank I.
    J Urol; 2013 Jul; 190(1):55-60. PubMed ID: 23313198
    [Abstract] [Full Text] [Related]

  • 14. The prognostic impact of perioperative blood transfusion on survival in patients with bladder urothelial carcinoma treated with radical cystectomy.
    Lee JS, Kim HS, Jeong CW, Kwak C, Kim HH, Ku JH.
    Korean J Urol; 2015 Apr; 56(4):295-304. PubMed ID: 25874043
    [Abstract] [Full Text] [Related]

  • 15. Restrictive transfusion in radical cystectomy is safe.
    Syan-Bhanvadia S, Drangsholt S, Shah S, Cai J, Miranda G, Djaladat H, Daneshmand S.
    Urol Oncol; 2017 Aug; 35(8):528.e15-528.e21. PubMed ID: 28476526
    [Abstract] [Full Text] [Related]

  • 16. Comparative outcomes of primary, recurrent, and progressive high-risk non-muscle-invasive bladder cancer.
    Thomas F, Noon AP, Rubin N, Goepel JR, Catto JW.
    Eur Urol; 2013 Jan; 63(1):145-54. PubMed ID: 22985746
    [Abstract] [Full Text] [Related]

  • 17. Patterns and timing of perioperative blood transfusion and association with outcomes after radical cystectomy.
    Diamantopoulos LN, Sekar RR, Holt SK, Khaki AR, Miller NJ, Gadzinski A, Nyame YA, Vakar-Lopez F, Tretiakova MS, Psutka SP, Gore JL, Lin DW, Schade GR, Hsieh AC, Lee JK, Yezefski T, Schweizer MT, Cheng HH, Yu EY, True LD, Montgomery RB, Grivas P, Wright JL.
    Urol Oncol; 2021 Aug; 39(8):496.e1-496.e8. PubMed ID: 33551249
    [Abstract] [Full Text] [Related]

  • 18. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience.
    Efstathiou JA, Spiegel DY, Shipley WU, Heney NM, Kaufman DS, Niemierko A, Coen JJ, Skowronski RY, Paly JJ, McGovern FJ, Zietman AL.
    Eur Urol; 2012 Apr; 61(4):705-11. PubMed ID: 22101114
    [Abstract] [Full Text] [Related]

  • 19. Perioperative Transfusion of Leukocyte-depleted Blood Products in Contemporary Radical Cystectomy Cohort Does Not Adversely Impact Short-term Survival.
    Chipollini JJ, Tang DH, Patel SY, Garcia-Getting RE, Gilbert SM, Pow-Sang JM, Sexton WJ, Spiess PE, Poch MA.
    Urology; 2017 May; 103():142-148. PubMed ID: 28011275
    [Abstract] [Full Text] [Related]

  • 20. Peri-operative allogeneic blood transfusion and outcomes after radical cystectomy: a population-based study.
    Siemens DR, Jaeger MT, Wei X, Vera-Badillo F, Booth CM.
    World J Urol; 2017 Sep; 35(9):1435-1442. PubMed ID: 28213861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.